Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03129438 : Continuous EEG Randomized Trial in Adults
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- In-patients aged ?18 years, treated in an ICU or intermediate care unit

- Alteration of mental state of any etiology (i.e., primarily cerebral or not), with
Glasgow-coma scale inferior or equal to 11 or FOUR score inferior or equal to 12.

- Need of an EEG to exclude seizures or SE, or to evaluate prognosis as per the treating
physician or the consulting neurologist.

- Informed consent obtained for research in emergency situation according to Human
Research Act (HRA) art 30-31 at the time of inclusion

Exclusion Criteria:

- Clinical and/or electrographic status epilepticus < 96h before randomization

- Clinical and/or electrographic seizure < 36h before randomization

- Palliative care situation, in which detection of SE or seizures would not have any
impact on the patient's care.

- High likelihood of needing a surgical intervention or an invasive diagnostic procedure
within the next 48 hours according to the treating physician (as this would require
cEEG removal).
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557